Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers
dc.contributor.author | Domino, Edward F. | en_US |
dc.contributor.author | Minoshima, Satoshi | en_US |
dc.contributor.author | Guthrie, Sally K. | en_US |
dc.contributor.author | Ohl, Linda | en_US |
dc.contributor.author | Ni, Lisong | en_US |
dc.contributor.author | Koeppe, Robert A. | en_US |
dc.contributor.author | Zubieta, Jon-Kar | en_US |
dc.date.accessioned | 2006-04-19T14:02:45Z | |
dc.date.available | 2006-04-19T14:02:45Z | |
dc.date.issued | 2000-12-01 | en_US |
dc.identifier.citation | Domino, Edward F.; Minoshima, Satoshi; Guthrie, Sally; Ohl, Linda; Ni, Lisong; Koeppe, Robert A.; Zubieta, Jon-Kar (2000)."Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers." Synapse 38(3): 313-321. <http://hdl.handle.net/2027.42/34989> | en_US |
dc.identifier.issn | 0887-4476 | en_US |
dc.identifier.issn | 1098-2396 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/34989 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=11020234&dopt=citation | en_US |
dc.description.abstract | The hypothesis for this research was that regional cerebral blood flow (rCBF) would increase following nasal nicotine administration to overnight abstinent tobacco smokers in relationship to the known brain distribution of nicotinic cholinergic receptors (nAChRs). Nine male and nine female healthy adult smokers were studied. They abstained overnight from tobacco products for 10 or more hours prior to study the next morning. Nicotine nasal spray was given in doses of 1–2.5 mg total with half in each nostril while the subject was awake and resting in a supine position. Oleoresin of pepper solution in a similar volume was used as an active placebo to control for the irritating effects of nicotine. Both substances were given single blind to the subjects. Positron emission tomography (PET) with H 2 15 O was used to measure rCBF. The data from each subject volunteer were normalized to global activity to better assess regional brain changes. Both nasal nicotine and pepper spray produced similar increases in CBF in somesthetic area II, consistent with the irritant effects of both substances. The mean rCBF effects of nasal pepper were subtracted from those of nasal nicotine to determine the actions of nicotine alone. The latter produced increases in rCBF in the thalamus, pons, Brodman area 17 of the visual cortex, and cerebellum. Some brain areas that contain a large number of nAChRs, such as the thalamus, showed an increase in CBF. Other areas that have few nAChRs, such as the cerebellum, also showed an increase in relative CBF. The hippocampal/parahippocampal areas showed greater regional decreases (left) and lesser increases (right) in CBF that correlated with the increase in plasma arterial nicotine concentrations. The results obtained indicate complex primary and secondary effects of nicotine in which only some regional brain CBF changes correlate with the known distribution of nAChR. No gender differences were noted. Synapse 38:313–321, 2000. © 2000 Wiley-Liss, Inc. | en_US |
dc.format.extent | 394801 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | John Wiley & Sons, Inc. | en_US |
dc.subject.other | Life and Medical Sciences | en_US |
dc.subject.other | Neuroscience, Neurology and Psychiatry | en_US |
dc.title | Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Molecular, Cellular and Developmental Biology | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pharmacology, University of Michigan, Ann Arbor, Michigan ; Department of Pharmacology, University of Michigan, Ann Arbor, MI 48109-0632 | en_US |
dc.contributor.affiliationum | Department of Internal Medicine (Nuclear Medicine), University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | College of Pharmacy, University of Michigan, Ann Arbor, Michigan ; Department of Psychiatry, University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Mental Health Research Institute, University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Pharmacology, University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Internal Medicine (Nuclear Medicine), University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Mental Health Research Institute, University of Michigan, Ann Arbor, Michigan ; Department of Psychiatry, University of Michigan, Ann Arbor, Michigan | en_US |
dc.identifier.pmid | 11020234 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/34989/1/10_ftp.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1002/1098-2396(20001201)38:3<313::AID-SYN10>3.0.CO;2-6 | en_US |
dc.identifier.source | Synapse | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.